Faithward Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-28,414
| Closed | -$1.76M | – | 275 |
|
|
2022
Q3 | $1.76M | Buy |
28,414
+3,839
| +16% | +$238K | 0.42% | 53 |
|
|
2022
Q2 | $1.96M | Buy |
24,575
+192
| +0.8% | +$15.3K | 0.44% | 50 |
|
|
2022
Q1 | $2.57M | Buy |
24,383
+1,243
| +5% | +$131K | 0.5% | 47 |
|
|
2021
Q4 | $2.49M | Sell |
23,140
-8,682
| -27% | -$935K | 0.47% | 48 |
|
|
2021
Q3 | $3.49M | Buy |
31,822
+57
| +0.2% | +$6.24K | 0.68% | 39 |
|
|
2021
Q2 | $2.97M | Buy |
31,765
+1,236
| +4% | +$116K | 0.59% | 44 |
|
|
2021
Q1 | $2.81M | Sell |
30,529
-123
| -0.4% | -$11.3K | 0.63% | 43 |
|
|
2020
Q4 | $2.24M | Sell |
30,652
-1,163
| -4% | -$85.1K | 0.98% | 24 |
|
|
2020
Q3 | $2.47M | Buy |
+31,815
| New | +$2.47M | 0.6% | 47 |
|